Results 221 to 230 of about 59,004 (282)
Some of the next articles are maybe not open access.
Clinics in Dermatology, 2006
Dermatomyositis is one of the idiopathic inflammatory myopathies. It is characterized clinically by progressive symmetrical proximal muscle weakness and a characteristic rash. There are patients with rash who have little or no muscle disease. Although the process primarily attacks the skin and the muscles, it is a systemic disease with frequent ...
Jeffrey P, Callen, Robert L, Wortmann
openaire +2 more sources
Dermatomyositis is one of the idiopathic inflammatory myopathies. It is characterized clinically by progressive symmetrical proximal muscle weakness and a characteristic rash. There are patients with rash who have little or no muscle disease. Although the process primarily attacks the skin and the muscles, it is a systemic disease with frequent ...
Jeffrey P, Callen, Robert L, Wortmann
openaire +2 more sources
Arthritis & Rheumatology, 2020
To establish predictive models for mortality in patients with polymyositis/dermatomyositis–associated interstitial lung disease (PM/DM‐ILD) using a combination of initial serum biomarker levels.
T. Gono +17 more
semanticscholar +1 more source
To establish predictive models for mortality in patients with polymyositis/dermatomyositis–associated interstitial lung disease (PM/DM‐ILD) using a combination of initial serum biomarker levels.
T. Gono +17 more
semanticscholar +1 more source
British Journal of Hospital Medicine, 2012
Dermatomyositis is an idiopathic acute inflammatory disorder, characterized by inflammation of skeletal muscle, progressive symmetrical proximal myopathy and classical cutaneous manifestations. It affects both children and adults, and women more frequently than men.
Satveer, Mahil +3 more
openaire +2 more sources
Dermatomyositis is an idiopathic acute inflammatory disorder, characterized by inflammation of skeletal muscle, progressive symmetrical proximal myopathy and classical cutaneous manifestations. It affects both children and adults, and women more frequently than men.
Satveer, Mahil +3 more
openaire +2 more sources
Autologous CD19‐Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis
Arthritis & RheumatologyThe aim of this study is to report the safety and efficacy of CD19‐targeting chimeric antigen receptor (CAR) T cells in a child with refractory juvenile dermatomyositis (JDM).
R. Nicolai +15 more
semanticscholar +1 more source
Neutrophil Extracellular Traps in Tissue and Periphery in Juvenile Dermatomyositis
Arthritis & Rheumatology, 2020Neutrophils are key immune cells participating in host defense through several mechanisms, including the formation of neutrophil extracellular traps (NETs). This study was undertaken to investigate the role of neutrophils in juvenile dermatomyositis (JDM)
Bhargavi Duvvuri +7 more
semanticscholar +1 more source
Clinical and Experimental Dermatology, 1979
This Patient Page describes the symptoms, diagnosis, and treatment of dermatomyositis.
openaire +6 more sources
This Patient Page describes the symptoms, diagnosis, and treatment of dermatomyositis.
openaire +6 more sources
Zeitschrift für Rheumatologie, 2009
Dermatomyositis (DM) is a systemic inflammatory disease involving skin, muscles and other organs. Immunologically mediated inflammation of small vessels leads to vascular damage, especially of the muscular tissue. Typically DM presents clinically with DM-type local or generalized rash and proximal muscular weakness. Laboratory signs of muscular damage (
G, Stoltenburg-Didinger, E, Genth
openaire +2 more sources
Dermatomyositis (DM) is a systemic inflammatory disease involving skin, muscles and other organs. Immunologically mediated inflammation of small vessels leads to vascular damage, especially of the muscular tissue. Typically DM presents clinically with DM-type local or generalized rash and proximal muscular weakness. Laboratory signs of muscular damage (
G, Stoltenburg-Didinger, E, Genth
openaire +2 more sources
Update on dermatomyositis in adults
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2020Dermatomyositis (DM) in adults has a prevalence of 6–7 per 100,000 population per year. This dedicated compact overview was prepared due to an increasing incidence as well as an often underestimated systemic involvement and new developments in myositis ...
Nora Schlecht +3 more
semanticscholar +1 more source
Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress
Nature Reviews Rheumatology, 2023Xin Lu, Q. Peng, Guochun Wang
semanticscholar +1 more source
Arthritis & Rheumatology, 2019
To evaluate the expression of type I interferon (IFNα/β)– and type II IFN (IFNγ)–inducible genes in muscle biopsy specimens from patients with juvenile dermatomyositis (DM) and to correlate their expression levels with histologic and clinical features.
G. Moneta +10 more
semanticscholar +1 more source
To evaluate the expression of type I interferon (IFNα/β)– and type II IFN (IFNγ)–inducible genes in muscle biopsy specimens from patients with juvenile dermatomyositis (DM) and to correlate their expression levels with histologic and clinical features.
G. Moneta +10 more
semanticscholar +1 more source